NRAS and melanoma: Immunoblot analysis showed that NRAS ASO-1 did not substantially affect p-AKT levels (Fig. 2g), highlighting the specific inhibitory effect of ASO-mediated NRAS-mRNA depletion on the MAPK-signaling axis in NRAS-mutant melanoma.